The study involved two cohorts of cognitively healthy individuals divided based on the Aβ42/Tau CSF ratio (normal and AD prone group), and found no group differences in the macula or GCIPL, but a 10-μm difference in the thickness of the RNFL between the two groups [226]. This evidence concerns the gene MAPT and Alzheimer disease.